ARCHIVES

Gleevec Improves Survival Of CML In Accelerated Phase

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

NIH Challenge Grant Announcement

March 6, 2009

DCPC board Oks New Grant Program For Investigators

March 4, 1994

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

Funding Opportunities (8-page issue).

May 23, 2003

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986